您的位置:首页 > 产品中心 > T47D/S2
产品性质
biological source【生物来源】 | human breast |
growth mode【生长模式】 | Adherent |
morphology【形态学】 | polygonal epithelia |
technique(s) | cell culture | mammalian: suitable |
shipped in【运输】 | dry ice |
storage temp.【储存温度】 | −196℃ |
基本信息
General description【一般描述】 | Oestrogen receptor T47DS2 cells express ER alpha and progesterone receptor. |
Cell Line Description【细胞系描述】 | T47D/S2 cells have been established by reduction of the serum concentration to 2% fetal calf serum, in order to enable growth inhibition with tamoxifen. The T47D/S2 Cell line is the control cell line for the tamoxifen resistant T47D/TR-1 and T47D/TR-2 lines. |
Culture Medium【培养基】 | RPMI 1640 w/o Phenol Red (R7509) + 2% FBS (F2442) + 2.5 mM Ala-Gln (G8541) + 8μg/ml Insulin (I9278) |
Subculture Routine【传代培养常规】 | Split sub-confluent cultures (70-80%) 1:3 to 1:6 i.e. seeding at 2-4 x 10, 000 cells/cm² using 0.05% trypsin/EDTA; 5% CO2; 37℃. Recommend media change every 2-3 days |
Other Notes【其他说明】 | Cultures from PHE Culture Collections and supplied by Sigma are for research purposes only. Enquiries regarding the commercial use of a cell line are referred to the depositor of the cell line. Some cell lines have additional special release conditions such as the requirement for a material transfer agreement to be completed by the potential recipient prior to the supply of the cell line. Please view the Terms & Conditions of Supply for more information. |
Citation【引用】 | If use of this culture results in a scientific publication, it should be cited in the publication as: T47D/S2 (ECACC 16022512) |
产品说明
Disclaimer【免责声明】 | This cell line has special release conditions: Commercial organisations are required to complete the ′Cell Line Release Authorisation for Research Use in Commercial Organisations′ release conditions form. |